Zdrowie i gospodarka · 07/11/2022

FDA Releases Final Guidance for Studying Multiple Versions of Cellular or Gene Therapy Products in Early-Phase Clinical Trials

The FDA has released a final guidance document providing recommendations for sponsors interested in conducting early-phase clinical trials with multiple versions of cellular or gene therapy products for a single disease, aiming to gather preliminary evidence of safety and activity.